Literature DB >> 19950821

Reconstruction of hepatic veins by anastomosis with suprahepatic IVC in the posterior mediastinum in living donor liver transplantation for Budd-Chiari syndrome.

Shoji Kubo1, Tsuyoshi Ichikawa, Shigekazu Takemura, Kazuki Ohba, Takahiro Uenishi, Masao Ogawa, Shintaro Kodai, Hiroji Shinkawa, Shinji Uemoto.   

Abstract

In living donor liver transplantation for Budd-Chiari syndrome, it is necessary to eliminate interference with outflow from the liver without the replacement of the involved retrohepatic segment of the inferior vena cava. A 34-year-old female patient underwent living donor liver transplantation for Budd-Chiari syndrome. During surgery, the fibrous tissue surrounding the recipient inferior vena cava was dissected after removal of the recipient liver. The diaphragm was dissected and mobilized from the inferior vena cava on the cranial side to expose the intact inferior vena cava in the posterior mediastinum. The left and middle hepatic veins in the graft liver were anastomosed to a horizontal anastomotic orifice prepared in the anterior wall of the intact inferior vena cava in the posterior mediastinum. Anticoagulant therapy was begun after liver transplantation. Dynamic computed tomography after living donor liver transplantation demonstrated patent hepatic veins. The patient has been doing well, without any episode of thrombosis or occlusion of the graft hepatic veins at 1 year and 6 months after liver transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19950821

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Living donor liver transplantation for Budd-Chiari syndrome with hepatic inferior vena cava obstruction after open pericardial procedures.

Authors:  Akinari Fukuda; Yasuhiro Ogura; Hiroyuki Kanazawa; Akira Mori; Michiya Kawaguchi; Yasutsugu Takada; Shinji Uemoto
Journal:  Surg Today       Date:  2012-11-28       Impact factor: 2.549

2.  Living donor liver transplantation for Budd-Chiari syndrome: Overcoming a troublesome situation.

Authors:  Cengiz Ara; Sami Akbulut; Volkan Ince; Serdar Karakas; Adil Baskiran; Sezai Yilmaz
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.